Extracorporeal circulation of blood is not physiological, and results in activation of the complement system and leucocytes with consequent organ damage. [1] [2] [3] The technique of leucocyte depletion was developed in response to this, with early studies using either cell separator technology, or leucocyte-depleting transfusion filters incorporated into the extracorporeal circuit. [4] [5] [6] [7] The key benefits of leucodepletion are improved cardiac and lung function, especially an increased postoperative Pa o 2 . 4 5 The LeukoGuard LG-6 arterial line filter (Pall Biomedical, Portsmouth, UK), removes leucocytes from the circulation, although the systemic neutrophil count may 5 8-10 or may not be reduced. [11] [12] [13] Although one study demonstrated that the LG-6 removed mainly activated neutrophils, 12 markers of inflammation 9 13 and serum elastase, 11 are not reduced by leucocyte depletion.
Leucocyte depletion during cardiopulmonary bypass (CPB) may improve oxygenation in the early postoperative period in comparison with controls, 5 11 13 14 and the duration of postoperative mechanical ventilation may also be reduced, 5 11 although some of these studies have insufficient power 15 to detect the measured difference in main outcome variables. Also, the benefit of leucocyte depletion may be small if the duration of bypass is short. 16 Whilst there is a growing body of research concerned with the depletion of leucocytes during CPB, the majority of published work has concentrated on leucocyte depletion in patients with normal preoperative lung function. We undertook this prospective randomized study to evaluate the effect of leucocyte depletion in patients who have mild (sub-clinical) lung dysfunction.
Following local Ethics Committee approval and informed written consent, we studied 32 patients presenting for elective coronary artery bypass grafting. The exclusion criteria for the study are shown in Table 1 .
Lung function is not routinely measured preoperatively in our unit unless the patient has respiratory symptoms or a significant smoking history, so the patients were identified in the operating room from the first arterial blood-gas measurement taken before bypass. Lung dysfunction was defined as an alveolar-arterial oxygenation index 13 (AaOI, see below) greater than 1.25 (normal value in this age group is 0.2-0.55). All patients had normal preoperative haematology and biochemistry screening.
Patients were pre-medicated 1.5 h before the operation with morphine 10 mg i.m. and lorazepam 2 mg p.o.. Anaesthesia was induced with midazolam 2-4 mg, fentanyl 10-15 mg kg À1 , and pancuronium 0.2 mg kg À1 , and maintained using oxygen-enriched air (Fi o 2 0.4) and isoflurane. Intermittent positive pressure ventilation was adjusted to maintain Pa co 2 at 4.5-5.5 kPa with a tidal volume of 10-12 ml kg À1 and PEEP of 5 cm H 2 O. During the period of CPB, a propofol infusion was used at 2-3 mg kg À1 h À1 to maintain anaesthesia, and this was continued for sedation in the intensive care unit until extubation.
The CPB circuit consisted of a microporous hollow fibre oxygenator with integral cardiotomy reservoir (Dideco D703 Compactflo, Sorin Biomedica, Mirandola, Italy). The circuit tubing was made of PVC, with the exception of the pump head tubing, which was made of silicone. The circuit was primed with 2 litres of Hartmann's solution and 5000 iu of porcine heparin. The patients were prospectively randomized into two groups of 16 patients using a sealed envelope system. In the control group, the arterial line filter was a 40 mm woven polyester screen (D754, Sorin Biomedica), and in the study group a leucocyte-depleting arterial line filter (Leukogard LG-6, Pall Biomedical, Portsmouth, UK) was used. The LG-6 filter combines a 40-mm screen filter with a surface-modified fibre pack for the removal of leucocytes. Perfusion staff were aware of which filter was in the circuit, but surgical, anaesthetic, and theatre staff were not told which filter was being used. During CPB, all patients were cooled to a nasopharyngeal temperature of 31 C. Blood circulation was by roller pump (Stockert SIII, Munich, Germany) and pulsatile flow at 2.4 litre min À1 m À2 , reducing to 1.8 l min À1 m À2 during the period of hypothermia.
Following surgery, the patients were transferred to a dedicated cardiothoracic ITU where the staff were blinded to the type of filter used. Ventilation was continued with a Manley MP2000 ventilator using a tidal volume of 10 ml kg À1 at 10-12 b.p.m and no PEEP. Crystalloid fluid (4% dextrose, 0.18% saline) was given at 1 ml kg À1 h À1 and colloid (Gelofusine, B Braun, Melsungen, Germany) administration was titrated to maintain the pre-bypass central venous pressure. Blood and blood product administration was governed by a standard protocol, with a transfusion trigger of 80 g litre -1 . Patients were extubated by the anaesthetic resident on the ITU. The criteria for extubation were a nasopharyngeal temperature greater than 36 C, blood loss in the chest drains less than 1 ml kg À1 h À1 , and Pa o 2 greater than 9.0 kPa with an Fi o 2 of 0.4 or less. Neuromuscular block was not monitored or reversed. The time to extubation was recorded.
Blood samples were taken from the radial arterial line and the Fi o 2 was recorded at the following time points: 5 min after termination of CPB, and at 1, 2, 4, 8, and 18 h postoperatively. The AaOI (or respiratory index) was calculated from blood gas tensions using the formula:
Where: P bar =barometric pressure in kPa; Fi o 2 =inspired oxygen fraction; Ph 2 o=saturated vapour pressure of water at 37 C in kPa; Pa co 2 =arterial partial pressure of carbon dioxide in kPa; Pa o 2 =arterial partial pressure of oxygen in kPa.
Chest x-rays were taken preoperatively, then immediately and 24 h postoperatively. These films were later scored for lung water content using the Pistolesi scoring system, 17 by a radiologist blinded to the type of filter used. The Pistolesi system uses a number of easily identifiable markers on the chest x-ray to generate a numerical score for lung water content. The primary features are the number and distribution of Kerley's lines, and evidence of water accumulation around the bronchial tree ( Table 2) .
Statistical analysis
Statistical analysis of the data was carried out in a spreadsheet (Excel 97, Microsoft Corp., USA) using Student's t-test and two-way analysis of variance (ANOVA). A P value of <0.05 was considered statistically significant. We considered a difference in AaOI between the two groups of 0.5 to be clinically significant, and the sample size was calculated to give a power in excess of 0.8 to detect this difference. 
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Results
The two groups were comparable with respect to age, weight, body surface area (BSA), CPB time, aortic cross clamp time, and haematocrit during CPB (Table 3) . No patient bled significantly, and there were no differences between the groups in the nasopharyngeal temperature on arrival in the ITU or the time taken to re-warm to 36 C. Before the start of CPB, the AaOI was the same in both groups. Following CPB, the AaOI in the control group had increased significantly compared with baseline, while in the LG6 group it remained similar to the baseline value (between group difference, P<0.001 by ANOVA). This translates to a post-CPB Pa o 2 of 19.6 (7.3) kPa in the LG-6 group compared with 12.5 (4.3) kPa in the control group (P=0.02), at an Fi o 2 of 0.52 (0.19) and 0.53 (0.15), respectively. The difference in AaOI between the groups had disappeared by 18 h post-CPB (Table 4) .
The duration of postoperative ventilation was significantly shorter in the leucocyte-depleted patients, at 4.8 (2.1) h compared with 8.3 (4.7) h in the control group (P=0.041) ( Table 4) .
The Pistolesi scores were low in both groups before bypass (1.5 (1.1) in the leucodepleted group vs 1.3 (0.9) in the control group). There was a significant increase in the amount of extravascular lung water in both groups following CPB according to the Pistolesi scoring system (P<0.001 by ANOVA). However, the amount of lung water in the leucocyte-depleted patients was significantly less than controls both immediately following surgery (13.0 (8.6) vs 19.6 (10.8) for the control group, P=0.04), and at 24 h post-surgery (9.7 (7.7) vs 15.2 (9.9) for the control group, P<0.05).
Discussion
In 1983, Kirklin introduced the concept of a whole body inflammatory response caused by the interaction between blood and the foreign surface of the extracorporeal circuit. 18 This is known as material-dependent activation, and is characterized by activation of the complement system. As well as the immediate activation at the start of CPB, a second increase in complement activation is observed following release of the aortic cross clamp. 19 This reperfusion injury has been termed material-independent activation, but the mechanism underlying this source of activation remains unclear. However, activated leucocytes are a part of the final common pathway in the inflammatory process. 3 The duration of CPB was relatively short in our study, at between 60 and 65 min. This is of interest because, in low risk patients undergoing coronary revascularization, leucocyte filtration did not confer any significant preservation of lung function unless the duration of CPB exceeded 90 min. 16 However, in our study the use of leucocyte depletion in patients with mild lung dysfunction provides some preservation of oxygenation irrespective of the duration of CPB.
During this study, the decision to discontinue mechanical ventilation was taken by the anaesthetist in the ICU, who was blinded to the type of filter used during CPB. Our results are in keeping with previous studies that demonstrated improved oxygenation in the early postoperative period in leucocyte-depleted patients compared with controls, 5 11 13-15 with a reduction in the duration of postoperative mechanical ventilation. 5 11 Our routine practice at the time of this study was not to use PEEP, although this has now changed with the purchase of more sophisticated ventilators than those used for this study.
While the mean AaOI before CPB was around 1.8 in both groups (Table 4) , these were all patients who had no Leucocyte depletion and lung dysfunction symptoms of pre-existing pulmonary disorders, such as asthma or chronic obstructive pulmonary disease. It is possible that the reduction in exercise tolerance associated with coronary artery disease might have masked any symptoms that might otherwise be attributable to pulmonary dysfunction. However, although they may benefit from leucocyte depletion, these patients are difficult to identify preoperatively, so there may be an argument for the routine use of leucocyte-depleting arterial line filters during CPB.
